The Effects of Azithromycin on Dextran Sulfate Sodium Colitis in Mice
atmire.migration.oldid | 3249 | |
dc.contributor.advisor | Morck, Doug | |
dc.contributor.author | Anderson, Stefanie | |
dc.date.accessioned | 2015-05-20T19:30:59Z | |
dc.date.available | 2015-11-20T08:00:24Z | |
dc.date.issued | 2015-05-20 | |
dc.date.submitted | 2015 | en |
dc.description.abstract | Inflammatory bowel disease (IBD) is a heterogeneous group of chronic, relapsing inflammatory gastrointestinal diseases for which there is no cure. Many models of IBD exist, owing to the complex disease pathophysiology. Although immunosuppressants are mainstay treatments, antibiotics are frequently prescribed to decrease harmful bacteria, which can exacerbate immune responses. Azithromycin is a macrolide antibiotic with immunomodulatory functions that has been extensively studied in the airways, but few have examined its role in IBD. This project investigated several clinical, pathological, and immunomodulatory effects of azithromycin in a murine dextran sulfate sodium model of colitis. Azithromycin substantially mitigated clinical disease presentation, as assessed by animal behaviour, weight change, and gross pathology. However, these effects were not reflected on a microscopic, hematologic, or biochemical level, and no mechanism was found to explain them. The results highlight the importance of clinical assessment as a tool to determine therapeutic efficacy in colitis research. | en_US |
dc.identifier.citation | Anderson, S. (2015). The Effects of Azithromycin on Dextran Sulfate Sodium Colitis in Mice (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/28098 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/28098 | |
dc.identifier.uri | http://hdl.handle.net/11023/2261 | |
dc.language.iso | eng | |
dc.publisher.faculty | Graduate Studies | |
dc.publisher.institution | University of Calgary | en |
dc.publisher.place | Calgary | en |
dc.rights | University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | |
dc.subject | Animal Pathology | |
dc.subject | Immunology | |
dc.subject | Medicine and Surgery | |
dc.subject.classification | Inflammatory Bowel Disease | en_US |
dc.subject.classification | Azithromycin | en_US |
dc.subject.classification | Antibiotic | en_US |
dc.subject.classification | Immunology | en_US |
dc.subject.classification | Crohn's disease | en_US |
dc.subject.classification | Ulcerative Colitis | en_US |
dc.subject.classification | Macrolide | en_US |
dc.subject.classification | Dextran Sulfate Sodium | en_US |
dc.subject.classification | Immunomodulation | en_US |
dc.title | The Effects of Azithromycin on Dextran Sulfate Sodium Colitis in Mice | |
dc.type | master thesis | |
thesis.degree.discipline | Biological Sciences | |
thesis.degree.grantor | University of Calgary | |
thesis.degree.name | Master of Science (MSc) | |
ucalgary.item.requestcopy | true |